The Pennant Group, Inc. $PNTG Shares Newly Acquired by Counterpoint Mutual Funds LLC

Key Points

• Counterpoint Mutual Funds LLC acquired 24,109 shares of The Pennant Group during the third quarter, valued at approximately $940,000. Institutional investors collectively own 85.88% of PNTG.
• The Pennant Group reported quarterly earnings of $0.36 per share, exceeding the $0.33 analyst consensus, while revenue of $297.98 million also surpassed estimates.
• Analyst sentiment remains positive: six analysts rate PNTG a Buy and one a Hold, resulting in a consensus “Moderate Buy” rating and a $42.00 average price target.

Counterpoint Mutual Funds LLC purchased a new position in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 24,109 shares of the company's stock, valued at approximately $940,000. Counterpoint Mutual Funds LLC owned 0.07% of The Pennant Group at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. GAMMA Investing LLC lifted its holdings in The Pennant Group by 36.1% during the 3rd quarter. GAMMA Investing LLC now owns 2,134 shares of the company's stock valued at $83,000 after buying an additional 566 shares in the last quarter. Squarepoint Ops LLC boosted its position in The Pennant Group by 62.1% in the 2nd quarter. Squarepoint Ops LLC now owns 46,785 shares of the company's stock valued at $1,729,000 after buying an additional 17,916 shares during the period. Nykredit A S purchased a new stake in The Pennant Group in the 2nd quarter valued at about $29,000. Corient Private Wealth LP bought a new position in The Pennant Group in the 2nd quarter worth about $354,000. Finally, Grandeur Peak Global Advisors LLC bought a new position in The Pennant Group in the 2nd quarter worth about $6,644,000. Institutional investors own 85.88% of the company's stock.

The Pennant Group Price Performance

PNTG opened at $41.87 on Friday. The company has a market capitalization of $1.46 billion, a price-to-earnings ratio of 46.52, a PEG ratio of 2.73 and a beta of 1.25. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.48. The Pennant Group, Inc. has a 12-month low of $22.25 and a 12-month high of $42.74. The business's fifty day simple moving average is $39.38 and its 200-day simple moving average is $36.45.

The Pennant Group (NASDAQ:PNTG - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.03. The firm had revenue of $297.98 million during the quarter, compared to the consensus estimate of $288.71 million. The Pennant Group had a return on equity of 10.33% and a net margin of 2.93%. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. On average, equities research analysts anticipate that The Pennant Group, Inc. will post 1.18 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently commented on PNTG. Truist Financial raised their target price on shares of The Pennant Group from $42.00 to $48.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Wells Fargo & Company lifted their price target on shares of The Pennant Group from $45.00 to $46.00 and gave the company an "overweight" rating in a research note on Tuesday, August 11th. Wall Street Zen upgraded The Pennant Group from a "hold" rating to a "buy" rating in a report on Saturday, June 20th. Royal Bank Of Canada increased their price objective on The Pennant Group from $42.00 to $44.00 and gave the stock an "outperform" rating in a research note on Thursday, August 20th. Finally, Weiss Ratings raised The Pennant Group from a "buy (b-)" rating to a "buy (b)" rating in a research note on Wednesday, August 19th. Six equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, The Pennant Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $42.00.

The Pennant Group Profile

The Pennant Group, Inc NASDAQ: PNTG is a healthcare services company that operates businesses focused on home-based care and senior living. Through its affiliated companies, Pennant provides home health, hospice and personal care services, as well as residential senior living services for older adults with varying care needs.

Its home health operations offer clinical care and rehabilitation services in patients' homes, while its hospice businesses provide comfort-focused care and support for individuals with advanced illnesses and their families.

Want to see what other hedge funds are holding PNTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Pennant Group, Inc. (NASDAQ:PNTG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.